Revenue
2019
2020
2021
2022
2023
2024
2025
MDxHealth SA (MDXH)
Price$0.7484Cached quote
Net income
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $107.9M | $90.0M | $70.2M | $37.1M | $22.2M | $18.5M | $11.8M |
| Gross profit | $69.6M | $55.1M | $43.9M | $19.2M | $10.6M | $8.0M | $30,000 |
| Gross margin | 64.55% | 61.23% | 62.58% | 51.87% | 47.50% | 43.58% | 0.25% |
| Research & development | $10.3M | $10.6M | $6.4M | $5.5M | $5.6M | $4.5M | $9.0M |
| Operating expenses | $84.0M | $79.9M | $79,000 | $67,000 | $42,000 | $39,000 | $2.50B |
| Operating income | −$14.4M | −$24.7M | −$27.3M | −$37.9M | −$26.8M | −$27.1M | −$43.2M |
| Operating margin | −13.36% | −27.45% | −38.93% | −102.28% | −120.69% | −146.93% | −366.30% |
| EBITDA | −$12.5M | −$23.3M | −$25.0M | −$36.9M | −$26.0M | −$25.6M | −$41.6M |
| EBITDA margin | −11.63% | −25.90% | −35.56% | −99.68% | −116.74% | −138.66% | −352.94% |
| Net income | −$33.5M | −$38.1M | −$43.1M | −$44.0M | −$29.0M | −$28.7M | −$43.1M |
| Net profit margin | −31.07% | −42.28% | −61.40% | −118.86% | −130.41% | −155.27% | −365.72% |
| Basic EPSper basic share | -$0.67 | -$1.16 | -$1.66 | -$2.78 | -$2.38 | -$0.34 | -$0.69 |
| Diluted EPSper diluted share | -$0.67 | -$1.16 | -$1.66 | -$2.78 | $2.38 | $0.34 | -$0.69 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
Bleichroeder LP | 7.38M |
Bednarski Eric | 4.7M |
MVM Partners, LLC | 4.7M |
PERKINS CAPITAL MANAGEMENT INC | 1.41M |
CITADEL ADVISORS LLC | 509.67K |
JANE STREET GROUP, LLC | 503.22K |
GSA CAPITAL PARTNERS LLP | 481.99K |
RENAISSANCE TECHNOLOGIES LLC | 325.08K |
MILLENNIUM MANAGEMENT LLC | 228.51K |
Squarepoint Ops LLC | 200.28K |
XTX Topco Ltd | 195.04K |
HRT FINANCIAL LP | 184.48K |
BlackRock, Inc. | 147.06K |
Virtu Financial LLC | 134.18K |
McGarrity Michael | 95K |
Ground Swell Capital, LLC | 88.11K |
Tower Research Capital LLC (TRC) | 36.55K |
FAS Wealth Partners, Inc. | 22.63K |
Lido Advisors, LLC | 20.25K |
Cambridge Investment Research Advisors, Inc. | 20K |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data